Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2015;172:187–207.

Article  PubMed  Google Scholar 

Barone A, Lucarelli A, Onofrillo D, Verzegnassi F, Bonanomi S, Cesaro S, et al. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP). Blood Cells Mol Dis. 2015;55:40–7.

Article  PubMed  Google Scholar 

Young NS, editor. Epidemiology of aplastic anemia. In: Bone marrow failure syndromes. 1st ed. Philadelphia: WB Saunders Company; 1996. p. 1–46.

Peffault de Latour R. Transplantation for bone marrow failure: current issues. Hematology. 2016;2016:90–8.

Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Samarasinghe S, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol. 2015;171:585–94.

Article  CAS  PubMed  Google Scholar 

Chen J, Lee V, Luo CJ, Chiang AK, Hongeng S, Tan PL, et al. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Haematol. 2013;162:383–91.

Article  PubMed  Google Scholar 

Szpecht D, Gorczynska E, Kalwak K, Owoc-Lempach J, Choma M, Styczynski J, et al. Matched sibling versus matched unrelated allogeneic hematopoietic stem cell transplantation in children with severe acquired aplastic anemia: experience of the polish pediatric group for hematopoietic stem cell transplantation. Arch Immunol Ther Exp. 2012;60:225–33.

Article  Google Scholar 

Chung NG, Lee JW, Jang PS, Jeong DC, Cho B, Kim HK. Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia. Pediatr Transplant. 2013;17:387–93.

Article  CAS  PubMed  Google Scholar 

Dufour C, Pillon M, Socie G, Rovo A, Carraro E, Bacigalupo A, et al. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant. Br J Haematol. 2015;169:565–73. https://doi.org/10.1111/bjh.13297.

Article  PubMed  Google Scholar 

George B, Mathew V, Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogenic stem cell transplant is superior to immunosuppressive therapy in Indian children with aplastic anemia—a single center analysis of 100 patients. Pediatr Hematol Oncol. 2010;27:122–31.

Article  CAS  PubMed  Google Scholar 

George B, Mathew V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduces rejection and improve outcomes in Indian patients undergoing allogenic stem cell transplantation for severe aplastic anemia. Bone Marrow Transplant. 2007;40:13–8.

Article  CAS  PubMed  Google Scholar 

Young NS. Aplastic anemia. N Engl J Med. 2018;379:1643–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428–36.

Article  CAS  PubMed  Google Scholar 

Jeong DC, Chung NG, Cho B, Zou Y, Ruan M, Takahashi Y, et al. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children. Haematologica. 2014;99:664–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prata PH, Eikema DJ, Afansyev V, Bosman P, Smiers F, Diez-Martin JL, et al. Haploidentical transplantation and post-transplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT severe aplastic anemia working party. Bone Marrow Transplant. 2020;55:1050–8.

Article  CAS  PubMed  Google Scholar 

Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant. 2008;14:1057–63.

Article  CAS  PubMed  Google Scholar 

Peffault de Latour R, Purtill D, Ruggeri A, Sanz G, Michel G, Gandemer V, et al. Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. Biol Blood Marrow Transplant. 2011;17:78–85.

Article  PubMed  Google Scholar 

Xu LP, Zhang XH, Huang XJ. Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia. Bone Marrow Transplant. 2017;52:381–7.

Article  CAS  PubMed  Google Scholar 

Jaiswal SR, Bhakuni P, Zaman S, Bansal S, Bharadwaj P, Bhargava S, et al. T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia. Transpl Immunol. 2017;43–44:54–9. https://doi.org/10.1016/j.trim.2017.07.004.

DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4:1770–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iftikhar R, Chaudhry QN, Mahmood SK, Ghafoor T, Shahbaz N, Khan MA, et al. A novel TBI free conditioning protocol for haploidentical transplant in acquired aplastic anemia: (FluCAB-Prime). Bone Marrow Transplant. 2021;56:2309–11.

Article  PubMed  Google Scholar 

Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, et al. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2020;26:2311–7.

Article  CAS  PubMed  Google Scholar 

Hashem H, Rihani R, Shanap MA, Khattab E, Tbakhi A, Sultan I. Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies. Bone Marrow Transplant. 2022;57:304–5.

Article  CAS  PubMed  Google Scholar 

Ciurea SO, Cao K, Fernandez-Vina M, Kongtim P, Malki MA, Fuchs E, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensus guidelines for the detection and treatment of donor specific anti-HLA antibodies (DSA) in haploidentical hematopoietic cell transplantation. Bone Marrow Transplant. 2018;53:521–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rutella S, Filippini P, Bertania V, Pira GL, Altomare L, Ceccarelli S, et al. Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/Cd19-depleted haploidentical stem cell graft. J Transl Med. 2014;12:240.

Article  PubMed  PubMed Central  Google Scholar 

Kharya G, Bakane A, Agarwal S, Rauthan A. Pretransplant myeloid and immune suppression, upfront plerixafor mobilization and posttransplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease. Bone Marrow Transplant. 2021;56:492–504. https://doi.org/10.1038/s41409-020-01054-3.

Kharya G, Bakane AN, Rauthan AM. Pre-transplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies. Pediatr Blood Cancer. 2021;68:e28909. https://doi.org/10.1002/pbc.28909.

Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sanders JE. Stem-cell transplant preparative regimens. Pediatr Transplant. 1999;3(Suppl 1):23–34. https://doi.org/10.1034/j.1399-3046.1999.00073.x.

Article  PubMed  Google Scholar 

Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, et al. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases. Bone Marrow Transplant. 1999;23:861–5. https://doi.org/10.1038/sj.bmt.1701758.

Article  CAS  PubMed  Google Scholar 

Pei XY, Zhao XY, Xu LP, Wang Y, Zhang XH, Huang XJ, et al. Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantation. Bone Marrow Transplant. 2017;52:1556–62.

Article  CAS  PubMed  Google Scholar